| 000 | 01280 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515015026.0 | ||
| 264 | 0 | _c20060504 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a1545-9616 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNouri, Keyvan | |
| 245 | 0 | 0 |
_aThe incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide. _h[electronic resource] |
| 260 |
_bJournal of drugs in dermatology : JDD _cFeb 2006 |
||
| 300 |
_a182-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xadverse effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHerpes Simplex _xchemically induced |
| 650 | 0 | 4 |
_aHerpes Zoster _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aOxides _xadverse effects |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aRicotti, Carlos A | |
| 700 | 1 | _aBouzari, Navid | |
| 700 | 1 | _aChen, Halland | |
| 700 | 1 | _aAhn, Eugene | |
| 700 | 1 | _aBach, Ardalan | |
| 773 | 0 |
_tJournal of drugs in dermatology : JDD _gvol. 5 _gno. 2 _gp. 182-5 |
|
| 999 |
_c16097425 _d16097425 |
||